271 related articles for article (PubMed ID: 33650093)
21. Identification of Hub Genes to Regulate Breast Cancer Spinal Metastases by Bioinformatics Analyses.
He Y; Cao Y; Wang X; Jisiguleng W; Tao M; Liu J; Wang F; Chao L; Wang W; Li P; Fu H; Xing W; Zhu Z; Huan Y; Yuan H
Comput Math Methods Med; 2021; 2021():5548918. PubMed ID: 34055036
[TBL] [Abstract][Full Text] [Related]
22. Coexpression Network Analysis of Genes Related to the Characteristics of Tumor Stemness in Triple-Negative Breast Cancer.
Suo HD; Tao Z; Zhang L; Jin ZN; Li XY; Ma W; Wang Z; Qiu Y; Jin F; Chen B; Cao Y
Biomed Res Int; 2020; 2020():7575862. PubMed ID: 32766313
[TBL] [Abstract][Full Text] [Related]
23. Integrated analysis of differentially expressed genes and pathways in triple‑negative breast cancer.
Peng C; Ma W; Xia W; Zheng W
Mol Med Rep; 2017 Mar; 15(3):1087-1094. PubMed ID: 28075450
[TBL] [Abstract][Full Text] [Related]
24. Identification of CXCR4 and CXCL10 as Potential Predictive Biomarkers in Triple Negative Breast Cancer (TNBC).
Chuan T; Li T; Yi C
Med Sci Monit; 2020 Jan; 26():e918281. PubMed ID: 31924747
[TBL] [Abstract][Full Text] [Related]
25. Molecular Features of Triple Negative Breast Cancer: Microarray Evidence and Further Integrated Analysis.
He J; Yang J; Chen W; Wu H; Yuan Z; Wang K; Li G; Sun J; Yu L
PLoS One; 2015; 10(6):e0129842. PubMed ID: 26103053
[TBL] [Abstract][Full Text] [Related]
26. [Prognostic values of spindle checkpoint protein BUB1B in triple negative breast cancer].
Zhang PC; Zhong XR; Zheng H; Li L; Chen F; Shen MJ; Li YJ; Chen H; Cao SY; Bu H; Ye F
Zhonghua Bing Li Xue Za Zhi; 2021 Jun; 50(6):645-649. PubMed ID: 34078054
[No Abstract] [Full Text] [Related]
27. Identification of potential oncogenes in triple-negative breast cancer based on bioinformatics analyses.
Xiao X; Zhang Z; Luo R; Peng R; Sun Y; Wang J; Chen X
Oncol Lett; 2021 May; 21(5):363. PubMed ID: 33747220
[TBL] [Abstract][Full Text] [Related]
28. Higher levels of TIMP-1 expression are associated with a poor prognosis in triple-negative breast cancer.
Cheng G; Fan X; Hao M; Wang J; Zhou X; Sun X
Mol Cancer; 2016 Apr; 15(1):30. PubMed ID: 27130446
[TBL] [Abstract][Full Text] [Related]
29. Identification of Hub Genes and Pathways of Triple Negative Breast Cancer by Expression Profiles Analysis.
Li L; Huang H; Zhu M; Wu J
Cancer Manag Res; 2021; 13():2095-2104. PubMed ID: 33688252
[TBL] [Abstract][Full Text] [Related]
30. Hsa-mir-3163 and CCNB1 may be potential biomarkers and therapeutic targets for androgen receptor positive triple-negative breast cancer.
Qiu P; Guo Q; Yao Q; Chen J; Lin J
PLoS One; 2021; 16(11):e0254283. PubMed ID: 34797837
[TBL] [Abstract][Full Text] [Related]
31. Identification of ribosomal protein family in triple-negative breast cancer by bioinformatics analysis.
Lin Z; Peng R; Sun Y; Zhang L; Zhang Z
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33305312
[TBL] [Abstract][Full Text] [Related]
32. Prognostic Significance of CCNB2 Expression in Triple-Negative Breast Cancer.
Cao J; Sun S; Min R; Li R; Fan X; Han Y; Feng Z; Li N
Cancer Manag Res; 2021; 13():9477-9487. PubMed ID: 35002325
[TBL] [Abstract][Full Text] [Related]
33. Guanylate-binding protein-1 is a potential new therapeutic target for triple-negative breast cancer.
Quintero M; Adamoski D; Reis LMD; Ascenção CFR; Oliveira KRS; Gonçalves KA; Dias MM; Carazzolle MF; Dias SMG
BMC Cancer; 2017 Nov; 17(1):727. PubMed ID: 29115931
[TBL] [Abstract][Full Text] [Related]
34. Screening and identification of potential biomarkers in triple-negative breast cancer by integrated analysis.
Guo J; Gong G; Zhang B
Oncol Rep; 2017 Oct; 38(4):2219-2228. PubMed ID: 28849078
[TBL] [Abstract][Full Text] [Related]
35. A novel prognostic two-gene signature for triple negative breast cancer.
Alsaleem MA; Ball G; Toss MS; Raafat S; Aleskandarany M; Joseph C; Ogden A; Bhattarai S; Rida PCG; Khani F; Davis M; Elemento O; Aneja R; Ellis IO; Green A; Mongan NP; Rakha E
Mod Pathol; 2020 Nov; 33(11):2208-2220. PubMed ID: 32404959
[TBL] [Abstract][Full Text] [Related]
36. Gene regulatory pattern analysis reveals essential role of core transcriptional factors' activation in triple-negative breast cancer.
Min L; Zhang C; Qu L; Huang J; Jiang L; Liu J; Pinello L; Yuan GC; Shou C
Oncotarget; 2017 Mar; 8(13):21938-21953. PubMed ID: 28423538
[TBL] [Abstract][Full Text] [Related]
37. Secreted breast tumor interstitial fluid microRNAs and their target genes are associated with triple-negative breast cancer, tumor grade, and immune infiltration.
Terkelsen T; Russo F; Gromov P; Haakensen VD; Brunak S; Gromova I; Krogh A; Papaleo E
Breast Cancer Res; 2020 Jun; 22(1):73. PubMed ID: 32605588
[TBL] [Abstract][Full Text] [Related]
38. Integrated Bioinformatics Data Analysis Reveals Prognostic Significance Of SIDT1 In Triple-Negative Breast Cancer.
Wang Y; Li H; Ma J; Fang T; Li X; Liu J; Afewerky HK; Li X; Gao Q
Onco Targets Ther; 2019; 12():8401-8410. PubMed ID: 31632087
[TBL] [Abstract][Full Text] [Related]
39. Prognostic Value of a Glycolytic Signature and Its Regulation by Y-Box-Binding Protein 1 in Triple-Negative Breast Cancer.
Lai YW; Hsu WJ; Lee WY; Chen CH; Tsai YH; Dai JZ; Yang CC; Lin CW
Cells; 2021 Jul; 10(8):. PubMed ID: 34440660
[TBL] [Abstract][Full Text] [Related]
40. Identification of potential core genes in triple negative breast cancer using bioinformatics analysis.
Li MX; Jin LT; Wang TJ; Feng YJ; Pan CP; Zhao DM; Shao J
Onco Targets Ther; 2018; 11():4105-4112. PubMed ID: 30140156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
